Remgro Limited (JSE:REM) wants equal partner in possible Mediclinic International plc (LSE:MDC) buyout. Remgro looks to take its stake to 50% from 44.6%. Remgro, the investment holding company chaired by Johann Rupert, says it is looking for a 50-50 partnership in a possible buyout and delisting of its largest asset, Mediclinic.

At investor-day presentation on June 14, 2022, CEO Jannie Durand fielded a spate of questions over Mediclinic, and while he said the information he could provide was limited, the group was looking for an equal partnership - implying that Remgro is looking to take its stake in Mediclinic to 50% from its current 44.6%. "We will invest alongside an equal partner, and given our meaningful pre-existing stake, the incremental cheque size for us is relatively more manageable," said Durand.